Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for Bipolar Depression with Metabolic Syndrome
NCT00835120Phase 4Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Mar 2009
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pioglitazone in bipolar disorder (BD), sponsored by University Hospitals Cleveland Medical Center. Primary endpoint: Inventory of Depressive Symptomatology-Clinician Rated at 8 weeks. Started Mar 2009; status: completed.
02
Drugs
pioglitazone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00835120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00835120.